Metabolic and Hemodynamic Effects of the Inhibitors of Type 2 Sodium Glucose Co-transporters (ISGLT2) in Diabetic Patients With Heart Failure (GLUCOSUR-IC)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03741972 |
|
Recruitment Status :
Completed
First Posted : November 15, 2018
Last Update Posted : October 14, 2022
|
Sponsor:
Germans Trias i Pujol Hospital
Information provided by (Responsible Party):
Antoni Bayés Genís, Germans Trias i Pujol Hospital
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | April 4, 2022 |
| Actual Study Completion Date : | April 4, 2022 |